Nurix Therapeutics Inc (NRIX) stock news · rev $84.0M
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
This NRIX news page leads with what Nurix Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for NRIX yet. We will not pad this page with generic market recap.
Latest reported NRIX revenue for 2025-11-30 was $84.0M. Net income was -$264.5M. Revenue was up 54.0% from 2024-11-30 to 2025-11-30. NRIX currently screens at market cap $1.77B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the NRIX stock page; for the tape open the quote page.
NRIX stock news FAQ
What are NRIX's latest revenue and net income?
Latest cached Nurix Therapeutics Inc (NRIX) revenue for Nov 30, 2025 was $84.0M. Net income was -$264.5M. Statements: https://lician.com/financials/nrix
How did NRIX revenue change from the prior cached period?
Cached Nurix Therapeutics Inc (NRIX) revenue was up 54.0% from $54.5M (Nov 30, 2024) to $84.0M (Nov 30, 2025). Statements: https://lician.com/financials/nrix
What is NRIX's market cap?
Nurix Therapeutics Inc (NRIX) market cap is $1.77B on the latest cached fundamentals snapshot.
What kind of company is NRIX?
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Where is NRIX stock news listed?
Cached stock news for Nurix Therapeutics Inc (NRIX) is listed at https://lician.com/news/nrix. Filings: https://lician.com/sec/nrix
Not investment advice.